Concepedia

Publication | Closed Access

TPX-0005, a novel ALK/ROS1/TRK inhibitor, effectively inhibited a broad spectrum of mutations including solvent front ALK G1202R, ROS1 G2032R and TRKA G595R mutants

DOI

29

Citations

0

References

2016

Year

J. Jean Cui, Dayong Zhai, Wei Deng, Evan Rogers, Zixian Huang, Jeffrey Whitten, Y. Li
European Journal of Cancer

No additional data available for this publication yet. Check back later!